Marco Peradotto

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Pseudomonas Aeruginosa

Molecularly Imprinted

Machine Learning

Coronavirus Disease

Top Venues

Antibiotics (Basel, Switzerland)

Microbial drug resistance (Larchmont, N.Y.)

This page only lists publications with an associated author ORCID identifier.

Publications

Alessandro Bondi, Emanuele Koumantakis, Antonio Curtoni, Anna Maria Barbui, Marco Peradotto, Daniela Lombardi, Roberto Casale, Silvia Alizzi, Elisa Zanotto, Lorena Charrier, Rossana Cavallo, Cristina Costa
Epidemiology and Impact of Anti-Pneumococcal Vaccination and COVID-19 on Resistance of Streptococcus pneumoniae Causing Invasive Disease in Piedmont, Italy. Antibiotics (Basel, Switzerland) 13 (8) (2024)
Alessandro Bondi, Emanuele Koumantakis, Antonio Curtoni, Anna Maria Barbui, Marco Peradotto, Daniela Lombardi, Roberto Casale, Silvia Alizzi, Elisa Zanotto, Lorena Charrier, Rossana Cavallo, Cristina Costa
Epidemiology and Impact of Anti-Pneumococcal Vaccination and COVID-19 on Resistance of Streptococcus pneumoniae Causing Invasive Disease in Piedmont, Italy. Antibiotics (Basel, Switzerland) 13 (8) (2024)
Alessandro Bondi, Antonio Curtoni, Marco Peradotto, Elisa Zanotto, Matteo Boattini, Gabriele Bianco, Marco Iannaccone, Anna Maria Barbui, Rossana Cavallo, Cristina Costa
Performance Evaluation of BD Phoenix and MicroScan WalkAway Plus for Determination of Fosfomycin Susceptibility in Enterobacterales . Antibiotics (Basel, Switzerland) 12 (7) (2023)
Marco Peradotto, A Bondi, D Lombardi, P Bottino, E Zanotto, A M Barbui, R Cavallo
The impact of COVID-19 pandemic control on vaccine-preventable invasive bacterial diseases in Piedmont (Italy). Infection 50 (3) (2022)
Marco Peradotto, Alessandro Bondi, Gabriele Bianco, Marco Iannaccone, Anna Maria Barbui, Cristina Costa, Rossana Cavallo
Comparison of Three Different Commercial Methods for Fosfomycin Susceptibility Testing in Pseudomonas aeruginosa . Microbial drug resistance (Larchmont, N.Y.) 28 (9) (2022)